Delivery Order SPE2DE24DA010-SPE2D625F4U6V

Award Date 4/3/25
Potential Completion Date 4/8/25
Potential Value $9.5K
Federal Agency
Medical Supply Chain
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Santa Clara, CA 95054, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $14,850.00 fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc., a large medical device manufacturer, for the delivery of various cardiovascular medical devices and related supplies. The contract is not set aside and has an ultimate completion date of September 13, 2024. Abbott Laboratories, through its Abbott Vascular Inc. division, is a key supplier of advanced medical technologies to federal healthcare systems, particularly the...
This is a federal contract award to Abbott Laboratories Inc., a global healthcare company, by the Defense Logistics Agency (DLA). The $25,715.85 fixed-price delivery order is for the provision of cardiovascular medical devices and related services, including items such as stents, pacemakers, heart valves, and surgical implants. The contract has an ultimate completion date of May 2, 2025. Abbott Laboratories Inc. is the prime contractor and has established itself as a critical supplier of...
This contract award by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc. is for the delivery of cardiovascular medical devices, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and specialized surgical implants. The $9,500.00 fixed-price delivery order has an ultimate completion date of May 30, 2024. Abbott Laboratories Inc., through its Abbott Vascular Inc. division, is a major supplier of advanced medical technologies to federal healthcare...
This federal contract award, valued at $105,000.00, was issued by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The contract is a delivery order for fixed-price medical equipment with economic price adjustment, with a completion date of February 21, 2025. The products being delivered include a range of cardiovascular medical devices such as stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and...
This federal contract award, valued at $48,634.70, was issued by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc., a global healthcare company and medical device manufacturer. The contract is a Delivery Order under a larger Indefinite Delivery Vehicle (IDV), with a period of performance ending on July 31, 2024. The award covers the delivery of a range of cardiovascular medical devices and related equipment, including implantable cardiac monitors, surgical implants, and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA), with an ultimate completion date of July 30, 2024, to provide low voltage pacemakers. The contract, valued at $9,126.00, was awarded to Abbott Laboratories Inc. through its Abbott Vascular Inc. division, a large, multinational medical device manufacturer. There was no set-aside designation used for this award, indicating full and open competition. Abbott Laboratories Inc. has been awarded numerous federal...
This is a federal contract award from the Defense Logistics Agency (DLA) to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The $44,742.80 fixed-price delivery order is for the provision of cardiovascular medical devices, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and surgical implants. The ultimate completion date for this contract is October 25, 2024. This contract award is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $14,850.00, was issued by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The award is a Delivery Order contract with a fixed price and economic price adjustment pricing type. The contract has an ultimate completion date of January 31, 2025 and does not include a set-aside designation, indicating full and open competition. Abbott Laboratories Inc. is a major pharmaceutical and medical device...
This federal contract award, valued at $33,700.00, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The contract is a fixed-price delivery order for the delivery of cardiovascular medical devices, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and specialized surgical implants. The contract has an ultimate completion date of April 15, 2025....
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc., a global healthcare company, for the delivery of medical devices and supplies. The contract, valued at $18,308.00, has an ultimate completion date of April 15, 2025. It is not set aside for any specific business category. The contract is for the provision of cardiovascular medical technologies, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping...
  • SPE2DE24DA010
    Indefinite Delivery Contract
  • SPE2DE24DA010-SPE2D625F4U6V
    Delivery Order

This is a $9,500.00 fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc. for the provision of cardiovascular medical devices and related services. The contract has an ultimate completion date of April 8, 2025.

The award is associated with Abbott Laboratories' broader contractual relationship with the federal government, which includes numerous Indefinite Delivery Vehicles (IDVs) with the Department of Veterans Affairs (VA) and DLA. These IDVs enable streamlined procurement of a comprehensive range of the company's medical technologies, including pacemakers, heart valves, cardiac mapping systems, and other specialized surgical implants. The contract award does not include any set-aside designations, indicating full and open competition.

Generated 7/6/25, 12:45 AM